What the Evidence Does NOT Show Because the marketing around these compounds is expansive, it is worth stating explicitly what the published record does not establish: It does not show that cagrilintide is superior, equal, or inferior to tirzepatide no head-to-head trial exists, so any ranking is cross-trial inference
It's a synthetic peptide, a short chain of 15 amino acids, and it was derived from a protective protein found in human gastric juice
Its sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (abbreviation: WAGGDASGE)
Given the high heterogeneity, further studies are needed to confirm the results
Research Disclaimer: While this article includes scientific references, much of the existing literature on therapeutic peptides involves animal studies, preclinical data, or early-stage human research, and may not be conclusive
TB-500 (Thymosin Beta-4) Research Wound Healing, Angiogenesis & Keratinocyte Migration (PubMed, 1999) A foundational pre-clinical study published on PubMed investigated Thymosin Beta-4 (TB4) in a rat full-thickness wound model
